Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02780219 · ClinicalTrials.gov registry record · NA
Chronic Obstructive Pulmonary Disorder and Acute Exercise
A NA study, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT02780219: Completed NA study, sponsored by Texas A&M University.
NCT02780219 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 57 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02780219, a NA study, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
For this study a resistance bout will be performed in order to promote the robust response of protein synthesis. Type II muscle fibers often exhibit more atrophy than type I fibers in COPD subjects therefore specifically targeting them in an exercise protocol could have more beneficial outcome for these individuals.
Primary Outcome
Change in whole-body protein synthesis rate
Interventions
- OTHER stable amino acid infusion
- OTHER acute exercise with amino acid infusion
- OTHER 24-hour post exercise amino acid infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-02-04 |
| Est. Completion | 2020-03-06 |
| Phase | NA |
What the finished NCT02780219 record still lists
NCT02780219 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which stable amino acid infusion is the first listed.
NCT02780219 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02780219 about?
NCT02780219 is a clinical study titled "Chronic Obstructive Pulmonary Disorder and Acute Exercise". For this study a resistance bout will be performed in order to promote the robust response of protein synthesis. Type II muscle fibers often exhibit more atrophy than type I fibers in COPD subjects therefore specifically targeting them in an exercise protocol could have more beneficial outcome for t...
What is the current status of trial NCT02780219?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2016-02-04. Estimated completion is 2020-03-06.
What interventions are being tested in trial NCT02780219?
The interventions under investigation include: stable amino acid infusion (OTHER), acute exercise with amino acid infusion (OTHER), 24-hour post exercise amino acid infusion (OTHER).
Who is sponsoring clinical trial NCT02780219?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02780219's enrollment target sits among peer trials
57 1261st of 2000 higher than 739 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI